Two Top Stories of NYSE: Huntington Bancshares Incorporated (NASDAQ:HBAN), AbbVie Inc. (NYSE:ABBV)

Huntington Bancshares Incorporated (NASDAQ:HBAN)

The shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) started off the last trading session with the price of $16.07 while closing the day with the price of $15.92. The shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) Fell -0.93% with the Loss of -0.15 points.

The shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) traded with the day volume of 8.47 Million shares whereas its average trading volume is 10.42 Million.

While analyzing the past performance of the stock we can see that the shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) Loss -3.4% in the last week while rising 0.38% in the last month. Past quarter performance shows the green light with 10.25%. The semi-annual and annual performance shows 24.76% and 15.95% respectively.

Some critical values of the shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) to be discussed here are: the beta which shows the value at 1.34 while Average True Range of Huntington Bancshares Incorporated (NASDAQ:HBAN) demonstrate the value at 0.34. The weekly and monthly volatility of the shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) are indicated at 1.97% and 2.10%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 49.08.

While studying the financial position of the shares of Huntington Bancshares Incorporated (NASDAQ:HBAN), we can see that the Market capitalization of the company is at 17.03 Billion. The shares outstanding for the company is 1.07 Billion and the shares float stands at 1.06 Billion. The income of the company stand at 987 Million while the sales stand at 3.43 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.87, Price to Earnings or P/E is at 18.36, Price to Sales P/S show the value of 4.96, the Return on Asset ROA stood at 0.011 and the Return on Equity ROE depicted at 0.116 while Return on Investment ROI is at 0.13.


AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) started its previous trading session at $113.74 and closed at $112.03 showing a Fell of -1.48 Percent.

The Company traded with an average Volume of 6.14 Million whereas, its Day Volume stood at 8.39 Million.

Looking at the performance of the stock, AbbVie Inc. (NYSE:ABBV) Loss -5.3% in the last week in its shares price and -2.5% in the last month. Quarterly performance shows a green of 16.33 Percent while Semi-Annual and Annual performances shows a 28.22 and 70.54 percent respectively.

Beta for AbbVie Inc. (NYSE:ABBV) stands at 1.49 while the ATR (average true range) is at 3.54. The Stock’s Weekly and Monthly Volatility is 3.10% and 2.89% respectively showing a RSI value of 45.

While studying the financial position of the shares of AbbVie Inc. (NYSE:ABBV), we can see that the Market capitalization of the company is at 179.81 Billion. The shares outstanding for the company is 1.61 Billion and the shares float stands at 1.59 Billion.

The Company generated an income of 8.88 Billion and the sales of 28.22 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $5.54 a share. P/E (price to earnings) and P/S (price to sales) values are 20.23 and 6.37 respectively.

The Return on Assets stands at 0.078, ROE shows a value of 0.927 and ROI for AbbVie Inc. (NYSE:ABBV) is 0.254 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment